These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 323185)

  • 1. Prediction of renal allograft rejection by direct lymphocyte blastogenesis assay.
    Uehling D; Segal M; Hussey J; Kan CM; Bach F
    Invest Urol; 1977 May; 14(6):431-3. PubMed ID: 323185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte spontaneous blastogenesis as a monitor of renal allograft rejection.
    Kanda H; Uemura T; Kunikata S; Matsuura T; Akiyama T; Kurita T
    Hinyokika Kiyo; 1990 Feb; 36(2):109-14. PubMed ID: 2343802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late acute rejection in long-term renal allograft recipients. Diagnostic and predictive value of circulating activated T cells.
    Reinke P; Fietze E; Döcke WD; Kern F; Ewert R; Volk HD
    Transplantation; 1994 Jul; 58(1):35-41. PubMed ID: 7913561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous blastogenesis as a monitor of renal allograft rejection.
    Kanda H; Kunikata S; Matsuura T; Akiyama T; Kurita T
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1592-4. PubMed ID: 3547869
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in peripheral blood lymphocyte nucleoli in a follow-up of renal allograft recipients. Correlation with the response to PHA.
    Korcáková L; Reneltová I; Hasková V; Svobodová J
    Z Immunitatsforsch Immunobiol; 1977 Feb; 152(5):363-8. PubMed ID: 320769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous blastogenesis and protein synthesis as monitors of renal allograft rejection.
    Thomas JH; Kinnaman ML; Pierce GE; Shaw LW; Clancy J
    Transplant Proc; 1984 Dec; 16(6):1600-2. PubMed ID: 6390871
    [No Abstract]   [Full Text] [Related]  

  • 7. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.
    Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intragraft mRNA cytotoxic molecule expression in renal allograft recipients.
    Carstens J; Ozbay A; Tørring C; Hansen HE
    Transpl Immunol; 2009 Mar; 20(4):212-7. PubMed ID: 19141320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of rejection on graft survival after renal transplantation.
    Lytton B; Finkelstein FO; Schiff M; Black HR
    Trans Am Assoc Genitourin Surg; 1975; 67():99-102. PubMed ID: 788307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical value of interleukin 1- and interleukin 2-determinations in patients after kidney transplantation].
    Buchwald S; Friemel H; Plantikow A; Hudemann B; Bast R; Templin R
    Allerg Immunol (Leipz); 1990; 36(3):137-45. PubMed ID: 2256457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients.
    Posselt AM; Vincenti F; Bedolli M; Lantz M; Roberts JP; Hirose R
    Transplantation; 2003 Jul; 76(1):190-5. PubMed ID: 12865808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum amyloid A protein: a sensitive indicator of renal allograft rejection in humans.
    Maury CP; Teppo A; Eklund B; Ahonen J
    Transplantation; 1983 Nov; 36(5):501-4. PubMed ID: 6356513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma alpha-2 glycomicroglobulin in monitoring allograft function and in predicting rejection episodes in kidney transplantation (preliminary results).
    Ayatse JO
    Acta Med Hung; 1989; 46(4):315-22. PubMed ID: 2636365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble interleukin 2 receptor (sIL-2R) levels in renal transplant recipients.
    Mehta R; Shah G; Adler W; Kittur D
    Clin Transplant; 2004; 18 Suppl 12():67-71. PubMed ID: 15217411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic capacity of serum amyloid A protein for early recognition of kidney allograft rejection.
    Casl MT; Bulatovic G; Orlić P; Sabljar-Matovinović M
    Nephrol Dial Transplant; 1995 Oct; 10(10):1901-4. PubMed ID: 8592601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious complications associated with renal transplantation: an analysis of risk factors.
    Ahern MJ; Comite H; Andriole VT
    Yale J Biol Med; 1978; 51(5):513-25. PubMed ID: 373266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary acidification in renal allografts.
    Graziani G; de Vecchi A; Ponticelli C
    Proc Eur Dial Transplant Assoc; 1975; 11():277-83. PubMed ID: 666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical predictors of chronic renal allograft rejection.
    Massy ZA; Guijarro C; Kasiske BL
    Kidney Int Suppl; 1995 Dec; 52():S85-8. PubMed ID: 8587291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.